EnteroMedics (ETRM) Reports In-Line Q2 EPS
Tweet
Share
E-mailEnteroMedics (NASDAQ: ETRM) reported Q2 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $79 thousand versus the consensus estimate of $50 thousand.
For earnings history and earnings-related data on EnteroMedics (ETRM) click here.
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
